AxoGen, Inc. (AXGN)

AxoGen Market Cap

AxoGen has a market cap or net worth of $642.98 million as of September 19, 2024. Its market cap has increased by 143.28% in one year.

• Market Cap: 642.98M
• Enterprise Value: 693.34M
• 1-Year Change: 143.28%
• Ranking: #2789
• Category: Small-Cap
• Stock Price: $14.67

Market Cap Chart

Since December 1, 1998, AxoGen's market cap has increased from $12.20M to $642.98M, an increase of 5,170.35%. That is a compound annual growth rate of 16.60%.

Market Cap History

Date	Market Cap	% Change
Sep 18, 2024	638.20M	117.07%
Dec 29, 2023	294.00M	-30.33%
Dec 30, 2022	422.00M	8.37%
Dec 31, 2021	389.40M	-45.79%
Dec 31, 2020	718.30M	1.73%
Dec 31, 2019	706.10M	-10.63%
Dec 31, 2018	790.10M	-16.55%
Dec 29, 2017	946.80M	219.76%
Dec 30, 2016	296.10M	98.19%
Dec 31, 2015	149.40M	113.43%
Dec 31, 2014	70.00M	-10.14%
Dec 31, 2013	77.90M	159.67%
Dec 31, 2012	30.00M	1.35%
Dec 30, 2011	29.60M	97.33%
Dec 31, 2010	15.00M	-12.79%
Dec 31, 2009	17.20M	45.76%
Dec 31, 2008	11.80M	118.52%
Dec 31, 2007	5.40M	100.00%
Dec 29, 2006	2.70M	28.57%
Dec 30, 2005	2.10M	-65.00%
Dec 31, 2004	6.00M	87.50%
Dec 31, 2003	3.20M	60.00%
Dec 31, 2002	2.00M	-60.78%
Dec 31, 2001	5.10M	-30.14%
Dec 29, 2000	7.30M	15.87%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Cytek Biosciences	665.42M
Scholar Rock Holding	661.87M
Astria Therapeutics	655.10M
SI-BONE	653.76M
Mereo BioPharma Group	648.21M
Humacyte	637.33M
Simulations Plus	629.24M
Revance Therapeutics	627.89M